Yuqi has over 7 years R&D experience in experiment design, modelling, chemical synthesis, characterisation and rapid prototyping. Yuqi qualified as a Biomaterial Scientist from University of Limerick, specialising in bone repair and bone implant, nanotechnology and microscopy. She disseminated over fifteen publications including journal papers and national and international conference papers and presentations. She was also a member of a leading physics group in Ireland – Modelling, Stimulation and Innovative Characterisation (MOSAIC) and carried out research work for BioElectricSurface FP7 with €1m investment from European Commission. Yuqi previously completed her MSc in Biomedical Science from NUI Galway where she accumulated solid knowledge in cardiology, tissue engineering and bone disease and treatments. Yuqi also worked as a Design Engineer in a world leading medical device company- Creganna Medical (TE) and previous R&D Engineer in other multinational companies. She has obtained extensive experience in minimally invasive devices from concept design phase to manufacturing, project management and customer relationship. In addition, Yuqi received a Diploma in Marketing, Advertising and Public Relations from Institute of Commercial Management, UK and a Diploma in International Trade and e-Commerce from Institute of International Trade of Ireland. With a good understanding of the Chinese Market, Yuqi was appointed as a VEC tutor for [Business Trading with China] course. Yuqi also has strong interests in Veterinary and Traditional Chinese Medicine. Yuqi is passionate about transferring her knowledge to commercialisation through the Bioinnovate Programme. In her spare time Yuqi likes music, swimming, skating and hiking.

Since the completion of the BioInnovate programme Yuqi Shaughnessy is working as the Project Lead of an Enterprise Ireland Commercialisation Fund project funded by the European Union. She and her team are developing a novel infant feeding device. The project commenced in NUIG in December 2018 and is expected to deliver a prototype device at the end of 2020. At that point a start-up company will be formed to carry the project forward towards commercialisation.